Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMGIN7J)

Drug Name	Onyvax-105 DMGIN7J
Synonyms	Antibody therapy (colerectal cancer), CRC/Onyvax; Vaccine (colorectal cancer), CRC/ImClone; Vaccine (colorectal cancer), CRC/Onyvax
Drug Type	Vaccine

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Prostate cancer	DISF190Y	2C82.0	Phase 1/2	[1]
------------------------------------------------------------------------------------

1 Discontinued in Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Colorectal cancer	DISNH7P9	2B91.Z	Discontinued in Phase 1	[2]
------------------------------------------------------------------------------------

References

1	Onyvax-105 Cancer Vaccine Shows Encouraging Clinical Results in Osteosarcoma Patients After Intensive Chemotherapy. Onyvax vaccines therapies. April 19, 2005.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006889)